Biotech's new financial layer.
Joined May 2022
- Tweets10.5K
- Following300
- Followers114K
- Likes25.1K
Pinned Tweet
September in the Biosphere 🌐
- Open Science Index: We launched a searchable directory with 6,720 scientific resources.
- Launchpad: We added credit-card wallet funding through Privy.
- New Bio website: We revamped our website, bringing BIOS, OpenLabs, Buildspace, Launchpad and Biofy together in one place.
- PeptAI: Selected for Track 2 of the Adaptyv Bio × Anthropic Protein Design Competition.
- NeuroLab Ignition Sale: The sale closed 2.2× oversubscribed, with more than 442K USDC committed by over 650 participants. NDT reward claims for veBIO stakers are now live on app.bio.xyz. We also refunded all BioXP spent on the Ignition Sale.
Read the full monthly report ↓
Research ideas deserve a place to develop before they’re ready for a paper.
OpenLabs (@openlabsbio) gives researchers a place to share a hypothesis and document what they find as they investigate it.
Explore what others are working on, or bring your own question.
Researchers need more ways to get their work funded.
Bio helps them develop their ideas and find people who want to back them.
OpenLabs (@openlabsbio) connects researchers with early support. Buildspace helps teams prepare to raise through the Bio launchpad, where communities can fund research they want to see happen.
Researchers need to know what an agent contributed and be able to check its work before taking it further.
On OpenLabs (@openlabsbio), humans and agents can contribute to research challenges with defined requirements and a named reviewer. That gives the work a specific question to answer and someone responsible for assessing it.
Our colleagues at @Molecule_sci explain how they’re handling access and contribution records within a lab with the researcher in control.
Researchers at @GoogleDeepMind, expect that as routine research is automated, the human scientist becomes "the principal, underwriting the actions of AI delegates". That depends on the scientist controlling what each agent may access and seeing what it did.
A Molecule Lab lets one researcher give each AI agent access to its data for a set period, revocable at any point, with every grant and every contribution logged against its author, including AI agents. PeptAI (@peptai_) already works this way, with an AI agent running peptide research under a human lead and reporting through its Lab.
September’s research updates from across the Bio ecosystem are here.
From @anagenxyz (HairDAO)'s early human pilot of slow-release minoxidil to @peptai_'s protein design competition entry, catch up on the work teams are working on↓
Being able to test a biological hypothesis digitally before committing to a lab experiment would change how we do science.
If these models become reliable enough, researchers could explore more possibilities and use the predictions to decide which experiments to run next.
Making those datasets open matters. A team working on a different disease can build on them, ask questions the original researchers never considered, and share what they find.
We're entering a new era of biology.
Today, Isomorphic Labs joins the Virtual Biology Initiative (VBI) as a founding member.
We are helping build an open resource for the global research community to accelerate how we understand and treat disease.
Read more here: isomorphiclabs.com/articles/…
Bio Protocol retweeted
Crypto is a dark forest. That is clear to all serious participants. We have priorities that address the issues that were observed in this launch:
- fix tokenomics
- incentivize capital formation, don't incentivize speculation
- smart contract logic > trust/promises (e.g. no fully liquid allocations to project/advisors)
- give projects an ecosystem to work and form an aligned community - before any token launch
- align scientific process with investor time-horizons
Onwards.
Update on NeuroLabs Ignition Sale
We want to clarify what happened during the launch and what we’re changing going forward.
1. Based on past launches, we intentionally didn’t communicate a specific finalization time to allow a buffer for the launch to finalize and for us to verify that everything was correct before distributing allocations. However, an outdated message from a previous deployment was still displayed on the finalization page, stating it would happen within 30 minutes. A disruption to our subgraph infrastructure delayed finalization leaving about an hour between the sale ending and TGE. We’re sorry for the wait.
2. We saw concerns about a wallet receiving tokens without participating in the Ignition Sale and selling shortly after. This wallet belonged to a NeuroLabs advisor and had been funded just before the launch. The advisor sold tokens representing 2.15% of the total supply.
NeuroLabs AI's tokenomics allocated 14.83% of the total supply to advisors, fully liquid at launch as communicated on the Bio launchpad sale page. We always recommend vesting for team, investor and advisor allocations but accepted the team's request to make the advisor allocation fully liquid for this launch. Going forward, we’ll enforce vesting for all team, investor and advisor allocations to better protect supporters.
3. From our side, we will refund all BioXP spent on the sale to all participants including those who purchased instant BioXP.
We believe DeSci should give projects the funding and community support to deliver on their roadmaps beyond the TGE.
We're building towards this through early community building and funding on OpenLabs, with permissionless launches and milestone-based funding in development for the Bio launchpad. The goal is to let projects focus on their scientific work, with supporters committed to that longer-term progress.
Thank you for your patience and continued trust as we build an ecosystem of tools and communities to move science forward.
BioXP Refund Update
All BioXP spent in the NeuroLab Ignition Sale has been refunded to every participant including those who purchased instant BioXP.
Refunds are automatic. No action is needed. Check your transaction history on the BioXP page: app.bio.xyz/bioxp
A full list of BioXP pledges and their resulting allocations will be available on the sale page shortly.
We're working closely with the NeuroLab team to support the project's long-term research and commercial development. Stay tuned for further updates.
A quick refresher on how the USDC raised in the sale is allocated:
• Initial raise: $200K
• 50% ($100K) went directly to NeuroLab to fund their research
• 50% ($100K) went into the LP
• Trading fees generated by the LP are split 70% to NeuroLab and 30% to Bio Protocol
Check our docs for a breakdown of how BioXP pledges determine sale allocations: docs.bio.xyz/bio/introductio…
Bio Protocol retweeted
The new PeptAI website is live 🧬
What's New:
• Pipeline overview: We’ve moved from a candidate view to a pipeline overview, making it easier to follow each project and see where everything stands.
• Start a project with us: Researchers and companies can now submit a research question or project idea through our contact form. Tell us what you’re working on and how we could help, and we’ll work with you to build a program around it.
Take a look ↓
Update on NeuroLabs Ignition Sale
We want to clarify what happened during the launch and what we’re changing going forward.
1. Based on past launches, we intentionally didn’t communicate a specific finalization time to allow a buffer for the launch to finalize and for us to verify that everything was correct before distributing allocations. However, an outdated message from a previous deployment was still displayed on the finalization page, stating it would happen within 30 minutes. A disruption to our subgraph infrastructure delayed finalization leaving about an hour between the sale ending and TGE. We’re sorry for the wait.
2. We saw concerns about a wallet receiving tokens without participating in the Ignition Sale and selling shortly after. This wallet belonged to a NeuroLabs advisor and had been funded just before the launch. The advisor sold tokens representing 2.15% of the total supply.
NeuroLabs AI's tokenomics allocated 14.83% of the total supply to advisors, fully liquid at launch as communicated on the Bio launchpad sale page. We always recommend vesting for team, investor and advisor allocations but accepted the team's request to make the advisor allocation fully liquid for this launch. Going forward, we’ll enforce vesting for all team, investor and advisor allocations to better protect supporters.
3. From our side, we will refund all BioXP spent on the sale to all participants including those who purchased instant BioXP.
We believe DeSci should give projects the funding and community support to deliver on their roadmaps beyond the TGE.
We're building towards this through early community building and funding on OpenLabs, with permissionless launches and milestone-based funding in development for the Bio launchpad. The goal is to let projects focus on their scientific work, with supporters committed to that longer-term progress.
Thank you for your patience and continued trust as we build an ecosystem of tools and communities to move science forward.
The $NDT token is officially live on @base.
Claim NDT on the Bio App: app.bio.xyz/agents/neurolab-…
CA: 0xd89e13e5faee17a8b4dd0739e0a9cab12b3828e3
→ NDT rewards are now live and claimable on the Bio app.
→ veBIO holders receive 20% of the total supply, 6-month linear vesting with 20% redeemable at TGE. Claiming early forfeits any unvested tokens.
Check out the NDT roadmap below
With NeuroLab AI, @NootropicsDAO_ is exploring how compounds could affect the brain, from cognition to potential side effects, and help researchers decide what to test in the lab.
Roadmap:
Roadmap
Q4 2026 targets:
• Atlas: Free user tier with 50 datasets and interactive knowledge graph exploration
• Axon: APIs, access for AI agents and third-party tool integrations
• Frontier: Expanded predictions for novel compounds and peptides
Q1 2027 targets:
• Workbench: Personal research libraries, compound comparisons and hypothesis drafting
• Cortex: Deeper causal reasoning and whole-brain mapping
• Commons: Community compound submissions, prioritisation voting and shared IP terms for novel candidates
Congratulations @NootropicsDAO_ on a successful close!
NDT Ignition Sale Closed
@NootropicsDAO_ has exceeded its funding goal.
2.2x oversubscribed
442,646 USDC committed by 651 participants.
→ TGE is expected shortly.
→ NDT staking and rewards will go live shortly after the TGE.
→ veBIO holders receive NDT rewards, with 20% claimable at TGE and the remaining 80% vesting linearly over six months. Claiming before full vesting forfeits any remaining unvested tokens.
→ The snapshot for veBIO rewards has already been taken.
